Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Hi-Tech Pharmacal, a specialty pharmaceutical company, has announced that the FDA has granted final approval to the company's abbreviated new drug application for dorzolamide and timolol ophthalmic solution, the generic for Merck's Cosopt.
Subscribe to our email newsletter
The product is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta blockers. Hi-Tech plans to launch generic dorzolamide and timolol ophthalmic solution immediately.